Peptide Research Reference: Trial Dosing Data & Reconstitution (2026)

Concentration and dose figures reported in the research literature are frequently misread, which is a common reason cited studies are difficult to interpret or reproduce. This reference covers laboratory reconstitution methodology, how concentration converts to volume on a syringe, the reference dose ranges reported in published trials, and how the BioRelix Peptide Concentration Calculator performs the conversion. For research reference only.

Step 1 — Reconstitution

Before a solution concentration can be determined, the lyophilised (freeze-dried) peptide powder is dissolved in bacteriostatic water. This laboratory process is called reconstitution.

Materials

• The peptide vial (lyophilised powder)
• Bacteriostatic water (3ml or 10ml vial)
• A 1ml insulin syringe (29–31G, 8mm)
• Two alcohol swabs

The Reconstitution Process

1. Wipe both vial tops with separate alcohol swabs and let dry fully
2. Draw the chosen volume of bacteriostatic water into the syringe
3. Insert the needle into the peptide vial at an angle — aim for the glass wall, not directly at the powder
4. Let the water run slowly down the side of the vial. Never expel forcefully — this degrades the peptide
5. Gently swirl (do not shake or vortex) until fully dissolved — the solution should run clear
6. Label the vial with the date reconstituted and the volume of BAC water added

Step 2 — Converting Concentration to Volume

Concentration figures are frequently misread in the literature. The arithmetic is simple, but errors here make reported study concentrations difficult to reproduce.

The Formula

Three numbers are needed:

• Peptide amount (mg) — on the vial label
• BAC water added (ml) — the reconstitution volume
• Reference dose (mcg) — as reported in the study protocol

The calculation:

1. Convert peptide to mcg: mg × 1,000 = mcg total
2. Calculate concentration: mcg ÷ ml water = mcg/ml
3. Calculate volume: reference dose ÷ concentration = ml
4. Convert to syringe units: ml × 100 = units on a U-100 syringe

Worked Example — BPC-157 10mg, 2ml BAC water, 250mcg dose

Step	Calculation	Result
Total mcg	10mg × 1,000	10,000 mcg
Concentration	10,000 mcg ÷ 2ml	5,000 mcg/ml
Draw volume	250 mcg ÷ 5,000 mcg/ml	0.05 ml
Syringe units	0.05 ml × 100	5 units

So for a 250mcg reference dose of BPC-157 from a 10mg vial reconstituted with 2ml BAC water, that concentration corresponds to the 5-unit line on a U-100 syringe.

Common Concentration Errors

Under-Concentration — The Most Common Misreading

Below the minimum effective concentration reported in the literature, published studies record no measurable outcome for a compound — regardless of its purity. Misreading concentration is the most frequently cited reason study results are hard to reproduce.

How the error occurs:

• Confusing mg with mcg — a 10mg vial contains 10,000mcg, not 10mcg
• Adding too much BAC water (e.g. 10ml instead of 2ml) without adjusting the volume — this dilutes the concentration by 5×, so 5× more volume corresponds to the same reference dose
• Miscounting syringe units — especially on a 0.3ml syringe where each unit is very small
• Working below the minimum effective concentration reported in the study literature

Over-Concentration — Less Common, More Noticeable

Preparing a solution more concentrated than the reference figure is harder to do accidentally but more immediately apparent. In trials, adverse effects reported in subjects varied significantly by compound class.

Compound Class	High-Dose Effects Reported in Trials	Notes
GLP-1 agonists (Retatrutide, Tirzepatide, Semaglutide)	Nausea, vomiting, fatigue, gastroparesis	Trial protocols titrated from 0.5–1mg, not the full dose
GHRH/GHS (CJC-1295, Ipamorelin, Tesamorelin)	Water retention, tingling hands/feet, lethargy	Evening administration reduced daytime effects in studies
Repair peptides (BPC-157, TB-500)	Generally well tolerated in models — nausea at very high doses	Wide reported tolerability window
Melanotan II	Nausea, facial flushing, spontaneous erections	Highly dose-sensitive — studies began at 100–200mcg
Selank / Semax	Drowsiness, mild headache	Intranasal administration has different bioavailability
Epitalon	Very well tolerated — no significant high-dose effects reported	Wide reported dosing window

Notes on Accurate Reconstitution & Handling

1. Record the Solution

A reconstitution log — date, compound, concentration, notes — keeps records consistent. In Bali's heat it is easy to lose track of how long a solution has been stored.

2. Label Every Vial Immediately After Reconstitution

Mark the vial with compound name, date reconstituted, and BAC water volume added. In a shared laboratory or cluttered fridge, unlabelled vials get mixed up — once reconstituted, peptides look identical.

3. Add More BAC Water if the Volume is Too Small to Measure

If a reference dose corresponds to only 1–2 units on the syringe, it is hard to measure accurately. A larger reconstitution volume increases the measured volume. Example: adding 4ml instead of 2ml to a 10mg vial halves the concentration but doubles the corresponding volume — 10 units instead of 5, which is more precise.

4. Use a 0.5ml Syringe for Low-Concentration Work

Below 20 units, a 0.5ml syringe gives better resolution than a 1.0ml syringe; each unit marking is larger. The concentration calculator switches between syringe sizes to show the difference.

5. Let the Alcohol Dry

Aseptic technique in the literature specifies allowing an alcohol-wiped surface to dry fully — a full 10–15 seconds — before piercing, so residual alcohol is not carried through the septum.

6. Storage Site Rotation in Long Studies

Repeated sampling from a single site is documented to cause tissue changes over time; study protocols rotate sampling points. Keeping a log makes rotation easy to track.

7. Store Correctly in Bali's Heat

Reconstituted peptides must be refrigerated (2–8°C). Bali's ambient temperature of 28–32°C degrades a reconstituted vial left on the counter within hours. Lyophilised (unreconstituted) peptides are more stable but should still be kept cool. Every BioRelix order ships in insulated cold-chain packaging for this reason.

8. Don't Freeze Reconstituted Peptides

Freezing a reconstituted vial causes ice crystal formation that physically damages the peptide structure. Freeze only lyophilised powder. Once water is added — refrigerate only.

Trial Dosing Reference for BioRelix Peptides

The ranges below are reference figures reported in published trials and laboratory literature, reproduced for research reference only. They are not instructions for human administration.

Peptide	Reported Trial Dose Range	Reported Frequency	Notes
Retatrutide	0.5–4mg	Weekly	Trials titrated from 0.5mg
Tirzepatide	2.5–7.5mg	Weekly	Trials titrated from 2.5mg
Semaglutide	0.25–2.4mg	Weekly	Standard titration in trials
BPC-157	250–500mcg	1–2× daily	Wide reported tolerability window
TB-500	2.5–5mg (loading) / 1mg (maintenance)	Weekly	Loading phase 4–6 weeks in studies
Ipamorelin	200–300mcg	1–3× daily	Studied before sleep
CJC-1295 No DAC	100–200mcg	3× daily	Studied with Ipamorelin
Tesamorelin	1–2mg	Daily	Consistent morning administration in trials
Epitalon	5–10mg	Daily × 10–20 days	Cycled protocol in studies
Selank	250mcg	1–3× daily	Intranasal or subcutaneous in research
Semax	300–600mcg	1–2× daily	Cognitive research protocols
Melanotan II	100–500mcg	Daily (loading) / 2–3× week (maint.)	Highly dose-sensitive
GHK-Cu	1–2mg	Daily	Subcutaneous or topical in studies
MOTS-c	5–10mg	2–3× weekly	Studied in the morning

Handling in Bali — Practical Considerations

The Heat Problem

Bali's climate accelerates peptide degradation. A reconstituted vial left at 30°C loses potency significantly faster than one kept at 4°C. If a laboratory fridge runs warm (some do — check with a thermometer), a portable cooler helps. Every BioRelix order ships in insulated cold-chain packaging precisely because of this.

Transporting Between Bali Areas

When moving samples between Canggu, Ubud, Seminyak, or Uluwatu, reconstituted vials should be kept in a small portable cooler or insulated bag with an ice pack. A 30-minute ride in direct sun can expose vials to 40°C+ temperatures.

Storage Interruptions

Reconstituted solutions degrade once the cold chain is broken; the literature advises discarding solutions left above 8°C for extended periods rather than returning them to storage. Lyophilised powder is more stable but should still be kept cool.

Frequently Asked Questions